How Industry Manipulates Authorship Guidelines
Author Information
Author(s): Alastair Matheson
Primary Institution: Independent Consultant
Hypothesis
The current ICMJE authorship guidelines are being exploited by the pharmaceutical industry to misattribute authorship.
Conclusion
The ICMJE guidelines should be revised to prevent the misattribution of authorship and ensure transparency in medical publications.
Supporting Evidence
- Industry uses the ICMJE guidelines to misattribute authorship.
- Current guidelines allow companies to conceal their contributions.
- Authorship practices can mislead readers about the origins of medical publications.
Takeaway
This study shows that companies can hide their role in writing medical papers by using certain rules about who gets to be called an author.
Methodology
The author used textual analysis and personal experience in the medical communications sector to examine industry practices.
Potential Biases
The author's background in the pharmaceutical industry may introduce bias in interpreting the data.
Limitations
The study is based on the author's personal experience and may not encompass all industry practices.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website